The 64-year-old patient, Brian Shelton, who participated in an early-stage clinical trial of an infusion treatment by Vertex Pharmaceuticals, said he now has "a whole new life."
Watch FISM News: [ Ссылка ]
Get the Latest News Updates on [ Ссылка ]
Connect with FISM News!
On Twitter: [ Ссылка ]
On Facebook: [ Ссылка ]
On Instagram: [ Ссылка ]
FISM TV's FISM News strives to cover the latest stories and to deliver the important facts and data from a biblical worldview. With a committed team of on-air, production, writing, and research, our crew is dedicated to bringing viewers the information they need to know.
FISM News November 29, 2021
© 2021 - FISM TV. All Rights Reserved
#diabetes #dt1 #stemcell #brianshelton #breakingnews #usnews #worldnews
